Pensions & Investments Logo
ETF Exchange > IBB ETF

IBB - ETF Fact Sheet

iShares Biotechnology ETF - USD

Fund Identification

Ticker

IBB

ISIN

US4642875565

Main Metrics

Price

$175.85

Expense Ratio

0.44%

AuM

$8,493.63M

Tracking Difference

-0.48%

Ratings

Trackinsight rating

ESG Consensus®

This fund’s exact Final Sustainability Grade is available in Trackinsight Enterprise.
Learn more about Trackinsight Enterprise

Official Investment Strategy

The iShares Biotechnology ETF seeks to track the investment results of an index composed of U.S.-listed equities in the biotechnology sector.

IBB's historical prices, performance, and flows

-2.00.02.04.06.0%
1m returns
6.42%
1m flows
$10M
* Net total returns
All data as of 14 April 2026

The ETF Exchange is brought to you by

State Street
With data and analysis by
Trackinsight
See all IBB data with a
free P&I Online account
Enjoy unlimited ETF searches and access to tear-sheets of over 4,000 North-American funds.

IBB's characteristics

Manager

Manager statistics

1739 funds, $5,950.34Bn in AUM

Benchmark

ICE Biotechnology Index (TR) - USD

Replication method

Direct (Physical)

Asset class

Equity

Dividend policy

Distributing

Meets ESG criteria

No
IBB's exposure

Countries

USA
96.13%

Sectors

Health Care
86.10%
Other
13.90%

Top 5 holdings

Other
13.89%
GILEAD SCIENCES
9.16%
VERTEX PHARMACEUTICALS
8.88%
AMGEN-T
8.81%
REGENERON PHARMACEUTICALS
6.68%
Total holdings
181
Total weight of top 5
47.42%
6.0%